Recognition of Research and Development Expenses
First written in FY2017-Q1. 8 of 36 entries say "Restated". Latest entry: FY2027-H1.
97 other companies' latest entry also says "Other".
- FY2027-H1R&D expenses increased in the interim periodAnnual report
「Total R&D expenses for the six-month interim consolidated period were ¥1,296 million.」
R&D expenses for the interim period were ¥1,296 million, an increase of ¥106 million from ¥1,190 million in the interim period of the previous fiscal year. - FY2026Full-year R&D expenses increased significantlyAnnual report
「Total R&D expenses for the fiscal year were ¥2,521 million.」
R&D expenses for FY2026 were ¥2,521 million, an increase of ¥384 million from ¥2,137 million in the previous fiscal year. - FY2026-H1R&D expenses increased in the interim periodAnnual report
「Total R&D expenses for the six-month interim consolidated period were ¥1,190 million.」
R&D expenses for the interim period were ¥1,190 million, an increase of ¥220 million from ¥970 million in the interim period of the previous fiscal year. - FY2025Full-year R&D expenses decreasedAnnual report
「Total R&D expenses for the fiscal year were ¥2,137 million.」
Full-year R&D expenses were ¥2,137 million, a decrease of ¥102 million from ¥2,239 million in the previous fiscal year. - FY2025-H1R&D expenses increased in the interim periodAnnual report
「Total R&D expenses for the six-month interim consolidated period were ¥970 million.」
R&D expenses for the interim period were ¥970 million, an increase of ¥134 million from ¥836 million in the interim period of the previous fiscal year. The company explained that there had been no material changes in its R&D activities. - FY2024Full-year R&D expenses increased significantlyAnnual report
「Total R&D expenses for the fiscal year were ¥2,239 million.」
Full-year R&D expenses increased by ¥335 million, from ¥1,904 million in the previous fiscal year to ¥2,239 million. - FY2024-Q3Cumulative third-quarter R&D expenses increasedAnnual report
「Total R&D expenses for the first three quarters of the current consolidated cumulative period were ¥1,572 million.」
R&D expenses for the first nine months were ¥1,572 million, an increase of ¥247 million from ¥1,325 million in the same period of the previous fiscal year. - FY2024-Q2Increase in research and development expenses for the cumulative second quarterAnnual report
「Total R&D expenses for the first six months of the fiscal year were ¥1,043 million.」
R&D expenses for the first six months were ¥1,043 million, an increase of ¥207 million from ¥836 million in the same period of the previous fiscal year. - FY2024-Q1First-quarter R&D expenses increasedAnnual report
「Total R&D expenses for the first quarter of the fiscal year were ¥527 million.」
R&D expenses were ¥527 million, an increase of ¥131 million from ¥396 million in the same period of the previous fiscal year. - FY2023Full-year R&D expenses increasedAnnual report
「Total R&D expenses for the fiscal year were ¥1,904 million.」
R&D expenses increased by ¥138 million, from ¥1,766 million in the previous fiscal year to ¥1,904 million. - FY2023-Q3Cumulative third-quarter R&D expenses increasedAnnual report
「Total R&D expenses for the first 3 quarters of the current fiscal year on a cumulative consolidated basis were ¥1,325 million.」
Cumulative R&D expenses for the first 3 quarters were ¥1,325 million, up ¥110 million from ¥1,215 million in the same period of the previous year. - FY2023-Q2Increase in research and development expenses for the cumulative second quarterAnnual report
「Total R&D expenses for the first 2 quarters of the current fiscal year on a cumulative consolidated basis were ¥836 million.」
Cumulative R&D expenses for the first 2 quarters were ¥836 million, up ¥27 million from ¥809 million in the same period of the previous year. - FY2023-Q1First-quarter R&D expenses increasedAnnual report
「Total R&D expenses for the first quarter of the current fiscal year on a cumulative consolidated basis were ¥396 million.」
R&D expenses were ¥396 million, up ¥32 million from ¥364 million in the same period of the previous year. - FY2022-Q3Cumulative R&D expenses for the first 3 quarters edged upAnnual report
「Total R&D expenses for the first 3 quarters of the current fiscal year on a cumulative consolidated basis were ¥1,215 million.」
Cumulative R&D expenses for the first 3 quarters were ¥1,215 million, up ¥5 million from ¥1,210 million in the same period of the previous year. - FY2022-Q2Cumulative R&D expenses for the first 2 quarters declinedAnnual report
「Total R&D expenses for the first 2 quarters of the current fiscal year on a cumulative consolidated basis were ¥783 million.」
R&D expenses were ¥783 million, down ¥26 million from ¥809 million in the same period of the previous year. - FY2022-Q1First-quarter R&D expenses increasedAnnual report
「Total R&D expenses for the first quarter of the current fiscal year on a cumulative consolidated basis were ¥384 million.」
R&D expenses were ¥384 million, up ¥20 million from ¥364 million in the same period of the previous year. - FY2021Full-year R&D expenses decreasedAnnual report
「Total R&D expenses for the current fiscal year on a consolidated basis were ¥1,647 million.」
R&D expenses decreased by ¥194 million from ¥1,841 million in the previous fiscal year to ¥1,647 million. - FY2021-Q3Nine-month R&D expenses decreasedAnnual report
「Total R&D expenses for the first 3 quarters of the current fiscal year on a cumulative consolidated basis were ¥1,210 million.」
Cumulative R&D expenses for the first 3 quarters were ¥1,210 million, down ¥152 million from ¥1,362 million in the same period of the previous year. - FY2021-Q2Cumulative R&D expenses for the first 2 quarters declinedAnnual report
「Total R&D expenses for the second quarter of the current consolidated cumulative period were ¥809 million.」
Cumulative R&D expenses for the first 2 quarters were ¥809 million, down ¥80 million from ¥889 million in the same period of the previous year. - FY2021-Q1First-quarter R&D expenses decreasedAnnual report
「Total R&D expenses for the first quarter of the current fiscal year on a cumulative consolidated basis were ¥364 million.」
R&D expenses were ¥364 million, down ¥84 million from ¥448 million in the same period of the previous year. - FY2020Full-year R&D expenses increasedAnnual report
「Total R&D expenses for the current fiscal year on a consolidated basis were ¥1,841 million.」
Full-year R&D expenses were ¥1,841 million, up ¥9 million from ¥1,832 million in the previous fiscal year. - FY2020-Q3RestatedAnnual report
「Total R&D expenses for the first 3 quarters of the current fiscal year on a cumulative consolidated basis were ¥1,324 million.」
Cumulative R&D expenses for the first 3 quarters were ¥1,324 million, down ¥38 million from ¥1,362 million in the same period of the previous year. They remained below the same period of the previous year for the second consecutive quarter. - FY2020-Q2Cumulative R&D expenses for the first 2 quarters declinedAnnual report
「Total R&D expenses for the first 2 quarters of the current fiscal year on a cumulative consolidated basis were ¥889 million.」
R&D expenses were ¥889 million, down ¥19 million from ¥908 million in the same period of the previous year. - FY2020-Q1First-quarter R&D expenses increasedAnnual report
「Total research and development expenses for the cumulative consolidated period through the first quarter were ¥448 million.」
R&D expenses were ¥448 million, up ¥24 million from ¥424 million in the same period of the previous year. - FY2019Full-year R&D expenses edged upAnnual report
「Total R&D expenses for the current fiscal year on a consolidated basis were ¥1,832 million.」
Full-year R&D expenses were ¥1,832 million, up ¥9 million from ¥1,823 million in the previous consolidated fiscal year. - FY2019-Q3RestatedAnnual report
「Total R&D expenses for the first 3 quarters of the current fiscal year on a cumulative consolidated basis were ¥1,362 million.」
Cumulative R&D expenses for the first 3 quarters were ¥1,362 million, unchanged from the same period of the previous year. - FY2019-Q2Increase in research and development expenses for the cumulative second quarterAnnual report
「Total R&D expenses for the first 2 quarters of the current fiscal year on a cumulative consolidated basis were ¥918 million.」
Cumulative R&D expenses for the first 2 quarters were ¥918 million, up ¥10 million from ¥908 million in the same period of the previous year. - FY2019-Q1First-quarter R&D expenses edged upAnnual report
「Total R&D expenses for the first quarter of the current fiscal year on a cumulative consolidated basis were ¥427 million.」
First-quarter R&D expenses were ¥427 million, up ¥3 million from ¥424 million in the same quarter of the previous year. - FY2018Full-year R&D expenses increasedAnnual report
「Total R&D expenses for the current fiscal year on a consolidated basis were ¥1,823 million.」
R&D expenses increased from ¥1,771 million in the previous consolidated fiscal year to ¥1,823 million. - FY2018-Q3RestatedAnnual report
「Total R&D expenses for the first 3 quarters of the current fiscal year on a cumulative consolidated basis were ¥1,362 million.」
Cumulative R&D expenses for the first 3 quarters were disclosed as ¥1,362 million. - FY2018-Q2RestatedAnnual report
「Total R&D expenses for the first 2 quarters of the current fiscal year on a cumulative consolidated basis were ¥908 million.」
Cumulative R&D expenses for the first 2 quarters were disclosed as ¥908 million. - FY2018-Q1RestatedAnnual report
「Total R&D expenses for the first quarter of the current fiscal year on a cumulative consolidated basis were ¥424 million.」
First-quarter R&D expenses were disclosed as ¥424 million. - FY2017RestatedAnnual report
「Total R&D expenses for the current fiscal year on a consolidated basis were ¥1,771 million.」
Full-year R&D expenses were disclosed as ¥1,771 million. - FY2017-Q3RestatedAnnual report
「Total R&D expenses for the first 3 quarters of the current fiscal year on a cumulative consolidated basis were ¥1,318 million.」
Cumulative R&D expenses for the first 3 quarters were disclosed as ¥1,318 million. - FY2017-Q2RestatedAnnual report
「Total R&D expenses for the first 2 quarters of the current fiscal year on a cumulative consolidated basis were ¥886 million.」
Cumulative R&D expenses for the period were disclosed as ¥886 million. - FY2017-Q1First statedAnnual report
「Total R&D expenses for the first quarter of the current fiscal year on a cumulative consolidated basis were ¥458 million.」
Total R&D expenses for the quarter were ¥458 million.